Latest News

Microbialtec Platform Develops Chemotaxonomy-based Drug Discovery to Accelerate The Development of Drug Discovery

Microbialtec, a high-tech service company that specializes in microbiological research-related issues. Microbialtec is dedicated to supporting researchers in exploring the potential of microbiology in the field of health, production and the environment. With years of experience, Microbialtec is capable to provide a one-stop microbiology solution to cover all stages from microbial sample collection to detection and analysis. Recently, it announced the release of its Chemotaxonomy-based Drug Discovery which can be applied to accelerate the development of drug discovery.

Based on customers' interests in chemically classified microbial drug discovery services, Microbialtec can isolate potential new compounds and clarify their structures on a larger scale. For new compounds, more analogs can be generated through combinatorial chemistry or traditional chemistry. Alternatively, an automated UV guided search can be used to complete a comprehensive screening of new but similar compounds. A holistic combination approach using comprehensive analysis and informatics techniques has recently been proposed as an intelligent screening strategy. Microbialtec can complete a comprehensive screening of new but similar compounds through automated UV guided searches. A holistic combination method using comprehensive analysis and informatics techniques has recently been proposed as an intelligent screening strategy.

Microorganisms play an important role in the development of natural product chemistry and medical treatments. Microbial metabolites are one of the most important cancer chemotherapy drugs. Many microbial compounds that can suppress the immune response have been discovered. There may be further applications in various fields of pharmacology, to promote development by screening using simple enzyme analysis before testing in intact animals.

Metabolomics can be used to identify and classify filamentous fungi, and can be used to discover new compounds when combined with modern dereplication methods. These methods are important for effective drug discovery strategies in the future, especially for de-duplication in culture collections, to avoid redundancy in species selection. This will maximize the chemical diversity of the microbial natural product library that can be produced from the fungal collection. Creative Biogene is the premier organization that provides professional and comprehensive metabolomics analysis services for partners in the pharmaceutical and academic research fields.

“As an expert in the field of microbiology, combined with rich project experience, strict data quality control and professional analysis process, Microbialtec will ensure that the service is carried out accurately and quickly.” said Marcia Brady, the marketing director of Creative Biogene, she also said, “Creative Biogene is committed to providing the best service to accelerate the realization of customer research goals, and can also provide a full range of personalized customized analysis services according to customer project requirements.”

About Microbialtec Platform
As a division of Creative Biogene, Microbialtec platform has an experienced technical team involving molecular biology, medicine, bioinformatics, statistical ecology. With 10 years of front-line scientific research experience, Creative Biogene supports customers with an overall microbiological research program and is capable to satisfy customized needs with affordable prices.